Eosinophils participate in the immune response against many pathogens, including viruses. Since mouse eosinophils are susceptible to influenza A virus infection and possess antiviral activity, we evaluated the expression of sialic acid residues in human eosinophils and their response against influenza virus in vitro. We demonstrated that human eosinophils express α2,6- and α2,3-linked sialic acid, and drastically reduced influenza virus titer. After influenza virus exposure, eosinophils upregulated retinoic acid-inducible gene I (RIG-I) mRNA expression, but no other pattern recognition receptors. Finally, high concentrations of interleukin-8 (IL-8) were found in influenza virus-exposed eosinophil cultures. These data suggest that human eosinophils possess antiviral activity and may play a role in the innate immune response to influenza virus.
Get full access to this article
View all access options for this article.
References
1.
AlemanF, LimHF, and NairP. Eosinophilic endotype of asthma. Eosinophilic endotype of asthma. Immunol Allergy Clin North Am, 2016; 36:559–568.
2.
BenitezAA, PanisM, XueJ, et al.In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep, 2015; 11:1714–1726.
3.
CarmoLAS, BonjourK, SpencerLA, et al.Single-cell analyses of human eosinophils at high resolution to understand compartmentalization and vesicular trafficking of interferon-gamma. Front Immunol, 2018; 9:1–10.
4.
DavoineF, and LacyP. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol, 2014; 5:570.
5.
DingJY, WangZH, ZhangZZ, et al.Effects of three IL-15 variants on NCI-H446 cell proliferation and expression of cell cycle regulatory molecules. Oncotarget, 2017; 8:108108–108117.
6.
DrakeMG, Bivins-smithER, ProskocilBJ, et al.Human and mouse eosinophils have antiviral activity against parainfluenza virus. Am J Respir Cell Mol Biol, 2016; 55:387–394.
7.
DyerKD, PercopoCM, FischerER, et al.Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood, 2009; 114:2649–2656.
8.
EdwardsMR, StrongK, CameronA, et al.Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness. J Allergy Clin Immunol, 2017; 140:909–920.
9.
Flores-TorresAS, Salinas-CarmonaMC, SalinasE, et al.Eosinophils and respiratory viruses. Viral Immunol, 2019; 32:198–207.
10.
HandzelZT, BusseWW, SedgwickJB, et al.Eosinophils bind rhinovirus and activate virus-specific T cells. J Immunol, 1998; 160:1279–1284.
11.
HeSH, SongCH, LiuZ, et al.Eosinophil-derived interferon-lambda contributes to initiation of allergen-related inflammation in the intestine. Cytokine, 2012; 58:186–192.
12.
HögnerK, WolffT, PleschkaS, et al.Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia. PLoS Pathog, 2013; 9:e1003188.
13.
Influenza (Avian and other zoonotic) Fact Sheet. World Health Organization, 2018. https://www.who.int/news-room/fact-sheets/detail/influenza-(avian-and-other-zoonotic) Accessed January4, 2021.
14.
Influenza Seasonal Fact Sheet. World Health Organization, 2016. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
15.
JurekaAS, KleinpeterAB, TipperJL, et al.The influenza NS1 protein modulates RIG-I activation via a strain-specific direct interaction with the second CARD of RIG-I. J Biol Chem, 2020; 295:1153–1164.
16.
KandaA, YasutakaY, van BuiD, et al.Multiple biological aspects of eosinophils in host defense, eosinophil-associated diseases, immunoregulation, and homeostasis: is their role beneficial, detrimental, regulator, or bystander?. Biol Pharm Bull, 2020; 43:20–30.
17.
KangH, WuWY, YuM, et al.Increased expression of TLR7 and TLR9 in alopecia areata. Exp Dermatol, 2020; 29:254–258.
18.
KumlinU, OlofssonS, DimockK, et al.Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir Viruses, 2008; 2:147–154.
19.
KvarnhammarAM, and CardellLO. Pattern-recognition receptors in human eosinophils. Immunology, 2012; 136:11–20.
20.
KvarnhammarAM, PettersonT, and CardellLO. NOD-like receptors and RIG-I-like receptors in human eosinophils: activation by NOD1 and NOD2 agonists. Immunology, 2011; 134:314–325.
21.
LeMessurierKS, RooneyR, GhoneimHE, et al.Influenza A virus directly modulates mouse eosinophil responses. J Leukoc Biol, 2020; 108:151–168.
22.
MånssonA, and CardellLO. Role of atopic status in Toll-like receptor (TLR)7- and TLR9-mediated activation of human eosinophils. J Leukoc Biol, 2009; 85:719–727.
23.
MånssonA, FranssonM, AdnerM, et al.TLR3 in human eosinophils: functional effects and decreased expression during allergic rhinitis. Int Arch Allergy Immunol, 2010; 151:118–128.
24.
MathurSK, FichtingerPS, KellyJT, et al.Interaction between allergy and innate immunity: model for eosinophil regulation of epithelial cell interferon expression. Ann Allergy Asthma Immunol, 2013; 111:25–31.
25.
NagaseH, OkugawaS, OtaY, et al.Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J Immunol, 2003; 171:3977–3982.
26.
PapadopoulosNG, ChristodoulouI, RohdeG, et al.Viruses and bacteria in acute asthma exacerbations—a GA2 LEN-DARE systematic review. Allergy, 2011; 66:458–468.
27.
PeteringH, GötzeO, KimmigD, et al.The biologic role of interleukin-8: functional analysis and expression of CXCR1 and CXCR2 on human eosinophils. Blood, 1999; 93:694–702.
28.
PetrovaVN, and RussellCA. The evolution of seasonal influenza viruses. Nat Rev Microbiol, 2017; 16:47–60.
29.
RosenbergHF, and DomachowskeJB. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J Leukoc Biol, 2001; 70:691–698.
30.
Sabogal PiñerosYS, BalSM, DijkhuisA, et al.Eosinophils capture viruses, a capacity that is defective in asthma. Allergy, 2019; 74:1898–1909.
31.
SamarasingheAE, MeloRC, DuanS, et al.Eosinophils promote antiviral immunity in mice infected with influenza A virus. J Immunol, 2017; 198:3214–3226.
32.
SauerAK, LiangCH, StechJ, et al.Characterization of the sialic acid binding activity of influenza A viruses using soluble variants of the H7 and H9 hemagglutinins. PLoS One, 2014; 9:1–9.
33.
SlaterL, BartlettNW, HaasJJ, et al.Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog, 2010; 6:e1001178.
34.
TiwaryM, RooneyRJ, LiedmannS, et al.Eosinophil responses at the airway epithelial barrier during the early phase of influenza A virus infection in C57BL/6 mice. Cells, 2021; 10:509.
35.
Van ReethK. Cytokines in the pathogenesis of influenza. Vet Microbiol, 2000; 74:109–116.
36.
VeerapandianR, SnyderJD, and SamarasingheAE. Influenza in asthmatics: for better or for worse?. Front Immunol, 2018; 9:1843.
37.
WennerasC, ZhuX, and ZimmermannN. Eosinophil trafficking. In: Lee, JJ, Rosenberg HF, eds. Eosinophils in Health and Disease. Amsterdam: Elsevier, 2013:121–166.
38.
WongCK, CheungPFY, IpWK, et al.Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol, 2007; 37:85–96.
39.
YoneyamaM, OnomotoK, JogiM, et al.Viral RNA detection by RIG-I-like receptors. Curr Opin Immunol, 2015; 32:48–53.
40.
ZhangZ, HuangT, YuF, et al.Infectious Progeny of 2009 A (H1N1) influenza virus replicated in and released from human neutrophils. Sci Rep, 2015; 5:1–11.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
